Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The hormonal implants market is seeing a critical pattern driven by the rising inclination for long-acting contraception methods. Hormonal implants, which give expanded prophylactic insurance a solitary inclusion, are gaining prominence among ladies looking for a dependable and helpful family planning choice.
The hormonal implants market is expanding past contraception to remember applications for menopausal hormone therapy. Hormonal implants are being investigated to convey controlled portions of hormones to reduce side effects of menopause, like hot glimmers and hormonal lopsided characteristics, offering ladies extra remedial options.
The worldwide spotlight on family planning drives is a critical driver of market patterns. Hormonal implants assume a vital part in family planning programs, particularly in creating areas, where access to contraception is fundamentally important. Government-supported drives and associations with non-benefit associations are adding to the far-reaching availability of hormonal implants.
The hormonal implants market is adding to endeavors to limit deviations in prophylactic access. The accessibility of hormonal implants in both created and creating districts helps address holes in family planning administrations, enabling ladies with different socioeconomic foundations to settle on regenerative decisions.
Producers are investigating hormonal implants with non-prophylactic advantages, for example, tending to health conditions past family planning. Implants conveying hormones for overseeing conditions like endometriosis, and polycystic ovary disorder (PCOS) are arising as helpful other options.
An arising pattern in the hormonal implants market is the investigation of biodegradable embed advances. Biodegradable implants offer the upside of taking out the requirement for expulsion systems, as they normally separate over the long run, diminishing the general invasiveness related with embed use.
The joining of telehealth administrations is affecting the hormonal implants market. Telehealth counsels furnish people with remote admittance to healthcare experts, working with conversations about prophylactic options, including hormonal implants, and supporting informed management.
Hormonal Implants Market Highlights:
Global Hormonal Implants Market Overview
Hormonal Implants Market Size was valued at USD 0.45 Billion in 2023. The Global Hormonal Implants industry is projected to grow from USD 0.47 Billion in 2024 to USD 0.72 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.98% during the forecast period (2024 - 2032).
Hormonal implants are a highly effective and very safe form of birth control in the shape of a tiny tube that is placed under the skin of a woman’s upper arm. The size of the implant is as small as a toothpick and are made of flexible plastic, the implant contains a type of progestin hormone that stops the ovaries from releasing eggs.
Additionally, higher safety from unwanted pregnancies, suitable government programs, raising awareness of contraceptives, and the growing research & development in the market is anticipated to fuel the market growth. For instance, a study stated that no pregnancy was observed in a control group of women, using the Etonogestrel-Releasing Contraceptive Implant, for a period of 5 years.
On the other hand, related cases of side-effects, pricing variation, and limited availability of the product are hampering the growth of the market during the assessment period. Moreover, major companies in the market are involved in research & development, collaborations, and mergers to sustain their position in the market.
For instance, in May 2016, ALLERGAN took an initiative to help the US military servicewomen access LILETTA at a Federal Supply Schedule (FSS) price of USD 55.83 to military treatment facilities nationwide. The initiative also includes an educational effort to raise contraception awareness among healthcare providers treating the US military servicewomen.
Hormonal Implants Market Segmentation
The global hormonal implants market has been segmented based on the hormone, type, distribution sector, end user, and region.
The market, based on the hormone, has been bifurcated into levonorgestrel and etonogestrel. The levonorgestrel segment is expected to hold a major share in the market due to the wider preferability and longer durability. The market, based on, distribution sector has been further sub-segmented into a public sector and private sector.
The public sector is expected to hold a major share, due to increasing adoption rates of hormonal implants in public healthcare facilities under various government regulations. The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The hormonal implants market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European hormonal implants market has been sub-divided into Western Europe and Eastern Europe.
Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hormonal implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hormonal implants market in the Middle East & Africa has been divided into the Middle East and Africa.
Hormonal Implants Market Key Players
- Bayer HealthCare
- Shanghai Dahua Pharmaceuticals Co., Ltd
- Merck & Co., Inc.
- Allergan
- Others
Hormonal Implants Market Regional Analysis
The market in the Americas is expected to dominate the global hormonal implants market due to the increasing per capita healthcare expenditure and the high adoption of new technology in the region.
According to government regulations, health insurance plans must cover all methods of birth control (including the implants), in the US, is expected to drive the market growth. Furthermore, increasing expenses in research by healthcare bodies is expected to fuel the growth of the market in this region.
The market in Europe showed a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system, an alternative for a surgical abortion, and the involvement of key companies. For instance, a study conducted by the European Journal of Contraception & Reproductive Health Care states that the most popular long-acting reversible contraception among European women were the levonorgestrel-releasing intrauterine system and copper intrauterine device. Therefore, the market is expected to grow during the forecast period.
The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing awareness for contraceptives and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low per capita disposable incomes in the region.
Global Hormonal Implants Market, by Hormone
- Levonorgestrel
- Etonogestrel
Global Hormonal Implants Market, by Type
- One Rod Device
- Two Rod Device
Global Hormonal Implants Market, by Distribution Sector
- Public Sector
- Private Sector
Global Hormonal Implants Market, By End User
- Hospitals & Clinics
- Academic & Research Institutes
Global Hormonal Implants Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Research and development (R&D) companies
- Medical device companies
- Government research institutes
- Academic institutes and universities
- Market research and consulting
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
